Intuitive Surgical Inc (ISRG)

219.07
+0.93(+0.43%)
After Hours
218.59
-0.48(-0.22%)
- Real-time Data
  • Volume:
    1,808,774
  • Day's Range:
    212.90 - 223.27
  • 52 wk Range:
    206.60 - 369.69

ISRG Overview

Prev. Close
218.14
Day's Range
212.9-223.27
Revenue
5.91B
Open
222.31
52 wk Range
206.6-369.69
EPS
4.49
Volume
1,808,774
Market Cap
78.64B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
2,149,628
P/E Ratio
48.83
Beta
1.26
1-Year Change
-20.34%
Shares Outstanding
358,956,511
Next Earnings Date
Jul 21, 2022
What is your sentiment on Intuitive Surgical?
or
Market is currently closed. Voting is open during market hours.

Intuitive Surgical Inc News

Intuitive Surgical Inc Analysis

  • Stocks That Will Defy Inflation

    Investors should remember that in times like this the best offense can be a good defenseThe rate of US inflation climbed again in January to 7.5% and stayed at a 40-year high....

  • Intuitive Surgical Is A Natural Buy

    Robotic surgery systems solutions provider Intuitive Surgical (NASDAQ:ISRG) stock is down (-18%) for the year outpacing the benchmark indexes. The maker of the da Vinci robotic...

Intuitive Surgical Inc Company Profile

Intuitive Surgical Inc Company Profile

Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system. The Company's products and related services enable physicians and healthcare providers to access minimally invasive care. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Its da Vinci products consist of five categories, such as da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. It also provides a suite of systems, learning, and services offerings. Its Ion endoluminal system extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Its services include readiness support, maintenance support, OR consulting, customer hospital analytics, and market consulting optimization.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellSell
Technical IndicatorsStrong BuyStrong BuyBuySellStrong Sell
SummaryStrong BuyStrong BuyBuySellStrong Sell
  • 300 to 210 in one month
    0
    • $200. AllIn
      0
      • What happened?
        0
        • On the conference call to discuss the results, management acknowledged the ongoing challenges related to the pandemic, which has resulted in order delays and patients continuing to postpone medical procedures. Management revised its guidance for procedure growth to a range of 12% to 16% for the full year, up from its previous guidance range of 11% to 15%. However, the company also acknowledged that its forecast "continues to reflect the uncertainty associated with the course of the pandemic," and that supply chain disruptions could further exacerbate the situation.
          0
        • according to The Motley Fool.
          0
      • 259
        0
        • 260 I'm going in.
          0
          • way over priced!!!
            1
            • Good lets make it better.
              0
              • 300
                0
                • 270
                  1
                  • 275
                    1